Zhangzhou Pientzehuang Pharmaceutical., Ltd

Shanghai Stock Exchange 600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd Revenue for the year ending December 31, 2023: USD 1.42 B

Zhangzhou Pientzehuang Pharmaceutical., Ltd Revenue is USD 1.42 B for the year ending December 31, 2023, a 12.45% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Zhangzhou Pientzehuang Pharmaceutical., Ltd Revenue for the year ending December 31, 2022 was USD 1.26 B, a -0.20% change year over year.
Zhangzhou Pientzehuang Pharmaceutical., Ltd Revenue for the year ending December 31, 2021 was USD 1.26 B, a 26.57% change year over year.
Zhangzhou Pientzehuang Pharmaceutical., Ltd Revenue for the year ending December 31, 2020 was USD 997.45 M, a 21.39% change year over year.
Zhangzhou Pientzehuang Pharmaceutical., Ltd Revenue for the year ending December 31, 2019 was USD 821.72 M, a 18.57% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shanghai Stock Exchange: 600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

CEO	Mr. Jin Ming Huang
IPO Date	June 16, 2003
Location	China
Headquarters	Pien Tze Huang Building
Employees	2,789
Sector	Health Care
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies

Description

Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. The company's products include medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health foods. The company is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd is a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.

Key trends

Past 5 years